Bangor Savings Bank’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $298 | Hold |
266
| – | – | ﹤0.01% | 531 |
|
|
2025
Q1 | $335 | Buy |
+266
| New | +$335 | ﹤0.01% | 532 |
|
|
2024
Q4 | – | Sell |
-267
| Closed | -$921 | – | 553 |
|
|
2024
Q3 | $921 | Hold |
267
| – | – | ﹤0.01% | 525 |
|
|
2024
Q2 | $1.35K | Hold |
267
| – | – | ﹤0.01% | 489 |
|
|
2024
Q1 | $2.26K | Hold |
267
| – | – | ﹤0.01% | 465 |
|
|
2023
Q4 | $1.09K | Hold |
267
| – | – | ﹤0.01% | 493 |
|
|
2023
Q3 | $800 | Hold |
267
| – | – | ﹤0.01% | 516 |
|
|
2023
Q2 | $8.24K | Hold |
267
| – | – | ﹤0.01% | 443 |
|
|
2023
Q1 | $13.2K | Hold |
267
| – | – | ﹤0.01% | 401 |
|
|
2022
Q4 | $7K | Hold |
267
| – | – | ﹤0.01% | 446 |
|
|
2022
Q3 | $18K | Hold |
267
| – | – | ﹤0.01% | 385 |
|
|
2022
Q2 | $11K | Buy |
+267
| New | +$11K | ﹤0.01% | 409 |
|